Clinical Trial Update: Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women [NA]

View source ↗

Summary

This completed clinical trial studied the effects of growth hormone administration on cardiovascular risk factors in women with growth hormone deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Growth Hormone (Somatropin) (somatropin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Growth Hormone Deficiency | NA | Status: COMPLETED